Alan H. Auerbach, President and CEO at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 94,344 shares at $3.53 ($333K) on 2025-07-08, disclosed to the SEC on 2025-07-10.
Scheduled sale ($333k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.53 | 25,592 | $90K | 27.1% |
| 2 | $3.53 | 25,592 | $90K | 27.1% |
| 3 | $3.54 | 21,580 | $76K | 22.9% |
| 4 | $3.54 | 21,580 | $76K | 22.9% |
| Total | $3.53 avg | 94,344 | $333K | 100% |
| Filing → |
| PBYI | SELL | 2025-01-03 | $213K | — | Filing → |
| PBYI | SELL | 2024-07-18 | $81K | — | Filing → |
| PBYI | SELL | 2024-07-02 | $124K | — | Filing → |